<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02822807</url>
  </required_header>
  <id_info>
    <org_study_id>2013-31</org_study_id>
    <secondary_id>2013-A00963-42</secondary_id>
    <nct_id>NCT02822807</nct_id>
  </id_info>
  <brief_title>Q Fever and Auto-immunity</brief_title>
  <acronym>Q Fever</acronym>
  <official_title>Q Fever and Auto-immunity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <brief_summary>
    <textblock>
      The IHU Mediterranean infection is national reference centre for Q fever. Coxiella burnetii
      is the bacteria responsible of this infection. The bacterium Coxiella burnetii infection is
      associated with secretion by the body both many antibodies against the bacteria but also
      against certain cells of the body (autoantibodies). These autoantibodies may have no effect
      or be associated with specific symptoms. Anti-Phospholipid antibodies are especially
      prevalent in the Q fever. Apart from this infection, they are associated with
      thrombocytopenia, obstetric complications, thrombosis and heart valve damage. These
      conditions have also been described as complications during Q fever. In a retrospective
      preliminary work on Q fever, we have shown that the presence of high levels of IgG
      anti-cardiolipin was associated with the presence of valvular and the evolution to
      endocarditis. Such associations have a therapeutic involvement and must therefore be
      confirmed. Indeed, if these associations were confirmed, a trans-esophageal ultrasound could
      be systematically proposed to patients with valvular disease of trans-thoracique ultrasound
      but IgG anticardiolipin high levels. Other special attention could be given to patients with
      high autoantibodies.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of a complication, linked to the rate of autoantibodies.</measure>
    <time_frame>2 years</time_frame>
    <description>The required complications are the followings:
endocarditis
thrombosis
thrombocytopenia
obstetrical complications:
Spontaneous miscarriage defined as a spontaneous expulsion of the embryo before 20 weeks gestation .
Spontaneous abortion
Fetal intrauterine death
Oligoamnios
Intrauterine growth retardation
Fetal malformations .</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of anti- cardiolipin antibodies</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of anti- phagosome autoantibodies</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Q Fever</condition>
  <condition>Auto-Immunity</condition>
  <arm_group>
    <arm_group_label>Q fever without valvular disease</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Q fever without valvular disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Q fever with valvular disease</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Q fever with valvular disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Q fever infective endocarditis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Q fever infective endocarditis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Other Coxiella burnetii infections (including pregnant women)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Other Coxiella burnetii infections (including pregnant women)</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood sampling</intervention_name>
    <arm_group_label>Q fever without valvular disease</arm_group_label>
    <arm_group_label>Q fever with valvular disease</arm_group_label>
    <arm_group_label>Q fever infective endocarditis</arm_group_label>
    <arm_group_label>Other Coxiella burnetii infections (including pregnant women)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with a current or former Q fever diagnosis

          -  Patient &gt; or = 18 years old.

          -  Patient who does not declined to have his medical records reviewed for research.

          -  Patient with health insurance.

        Exclusion Criteria:

          -  Minor patient (&lt;18 years )

          -  Adult patient under guardianship .

          -  Patient deprived of liberty or judgment.

          -  Patient refusing to sign the informed consent form .
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Didier RAOULT, PR</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Marseille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Didier RAOULT, Pr</last_name>
    <phone>04 91 38 55 14</phone>
    <phone_ext>+33</phone_ext>
    <email>didier.raoult@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alexandra Giuliani</last_name>
    <phone>04 91 38 28 70</phone>
    <phone_ext>+33</phone_ext>
    <email>alexandra.giuliani@ap-hm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assistance Publique - Hôpitaux de Marseille</name>
      <address>
        <city>Marseille Cedex 05</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Didier RAOULT, Pr</last_name>
      <phone>04 91 38 55 14</phone>
      <phone_ext>+33</phone_ext>
      <email>didier.raoult@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Alexandra GIULIANI</last_name>
      <phone>04 91 38 28 70</phone>
      <email>alexandra.giuliani@ap-hm.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2016</study_first_submitted>
  <study_first_submitted_qc>June 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 4, 2016</study_first_posted>
  <last_update_submitted>June 30, 2016</last_update_submitted>
  <last_update_submitted_qc>June 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fever</mesh_term>
    <mesh_term>Q Fever</mesh_term>
    <mesh_term>Autoimmune Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

